Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X.
Right arrow Articles by Chung, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X.
Right arrow Articles by Chung, D. C.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:712-719, 2005
© 2005 by the American Diabetes Association, Inc.

Overexpression of Cyclin D1 in Pancreatic ß-Cells In Vivo Results in Islet Hyperplasia Without Hypoglycemia

Xiaoboo Zhang1, John P. Gaspard1, Yusuke Mizukami1, Jingnan Li1, Fiona Graeme-Cook2, and Daniel C. Chung1

1 Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital Harvard Medical, Boston, Massachusetts
2 Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Cyclin D1 can stimulate proliferation by driving cells from the G1 into the S-phase of the mammalian cell cycle. Previous animal studies have implicated the G1-S transition as a key regulatory checkpoint governing the proliferation of pancreatic islet cells. We expressed cyclin D1 in the ß-cells of mice and islet hyperplasia developed in a time-dependent manner. The hyperplastic ß-cells exhibited higher rates of proliferation. However, blood glucose levels in fasting as well as nonfasting conditions remained normal. Furthermore, glucose tolerance tests demonstrated nearly normal responses, and diabetes did not develop in any of the animals. No islet cell tumors were observed, even among animals >2 years of age. Under our experimental conditions, the proliferative stimulus provided by cyclin D1 is not tumorigenic, does not result in diabetes, and does not result in hypoglycemia. Cyclin D1 may thus be considered a potential candidate to augment the ß-cell population ex vivo as a prelude to islet transplantation for diabetes.

Address correspondence and reprint requests to Daniel C. Chung, GRJ 825, Gastrointestinal Unit, Massachusetts General Hospital, 70 Blossom St., Boston, MA 02114. E-mail: chung.daniel{at}mgh.harvard.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Mol EndocrinolHome page
A. M Ackermann and M. Gannon
Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion
J. Mol. Endocrinol., February 1, 2007; 38(2): 193 - 206.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. C. Vasavada, I. Cozar-Castellano, D. Sipula, and A. F. Stewart
Tissue-Specific Deletion of the Retinoblastoma Protein in the Pancreatic {beta}-Cell Has Limited Effects on {beta}-Cell Replication, Mass, and Function
Diabetes, January 1, 2007; 56(1): 57 - 64.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
R. Yu, M. Cruz-Soto, S. L. Calzi, H. Hui, and S. Melmed
Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells.
J. Endocrinol., October 1, 2006; 191(1): 45 - 53.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. M. Vuguin, M. H. Kedees, L. Cui, Y. Guz, R. W. Gelling, M. Nejathaim, M. J. Charron, and G. Teitelman
Ablation of the Glucagon Receptor Gene Increases Fetal Lethality and Produces Alterations in Islet Development and Maturation
Endocrinology, September 1, 2006; 147(9): 3995 - 4006.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart
Molecular Control of Cell Cycle Progression in the Pancreatic {beta}-Cell
Endocr. Rev., June 1, 2006; 27(4): 356 - 370.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Luo, S. M. Liu, H. Liu, Q. Li, Q. Xu, X. Sun, B. Davis, J. Li, and S. Chua Jr.
Allelic Variation on Chromosome 5 Controls {beta}-Cell Mass Expansion during Hyperglycemia in Leptin Receptor-Deficient Diabetes Mice
Endocrinology, May 1, 2006; 147(5): 2287 - 2295.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. Cozar-Castellano, M. Weinstock, M. Haught, S. Velazquez-Garcia, D. Sipula, and A. F. Stewart
Evaluation of {beta}-Cell Replication in Mice Transgenic for Hepatocyte Growth Factor and Placental Lactogen: Comprehensive Characterization of the G1/S Regulatory Proteins Reveals Unique Involvement of p21cip
Diabetes, January 1, 2006; 55(1): 70 - 77.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.